[ad_1] The obesity drugs that powered huge investor gains in 2023 are poised to inspire…
Wholesalers
-
-
STOCK MARKET
Seven tech stocks that can broaden your exposure beyond the “Magnificent Seven”
by userby user[ad_1] During the bull market of 2023, the “Magnificent Seven” stocks have dominated financial media…
-
STOCK MARKET
Pfizer’s stock down 8% as 2024 profit and revenue guidance falls short of expectations
by userby user[ad_1] Pfizer Inc.’s stock PFE, -8.65% slid more than 8% early Wednesday, after the drug…
-
STOCK MARKET
Throw away those target-date funds, and don’t hold bonds at all, says this daring new research
by userby user[ad_1] The last Fed meeting of the year is upon us, as 2023 highs for…
-
STOCK MARKET
White House asserts authority to break patents of certain high-cost drugs
by userby user[ad_1] The Biden administration is taking steps to rein in the price of prescription drugs…
-
[ad_1] Financial-software company Bill Holdings Inc. announced Tuesday it will lay off 15% of its…
-
STOCK MARKET
Roche strikes $3.1 billion deal to buy obesity-drug maker Carmot Therapeutics billion in race to rival Novo Nordisk’s Ozempic
by userby user[ad_1] Roche has agreed to buy obesity-drug developer Carmot Therapeutics for up to $3.1 billion,…
-
STOCK MARKET
Pfizer’s stock falls 4% after halting trial of obesity drug due to side effects
by userby user[ad_1] Pfizer Inc.’s stock tumbled 4% premarket Friday, after the company said it would not…
-
STOCK MARKET
Buy now pay later is more popular than ever this holiday shopping season. Here are 3 things to know before you use it.
by userby user[ad_1] Barbie toys and robot vacuums are popular this holiday shopping season, and so are…
-
STOCK MARKET
SpringWorks stock on track for record gain after FDA approves first treatment for rare type of aggressive tumors
by userby user[ad_1] SpringWorks Therapeutics Inc. shares SWTX were on track for a record percentage gain on…